Evidence map›Paper›PMID 28852600›Full record

ReviewCureus2017

A Review on Antibiotic Resistance: Alarm Bells are Ringing.

Sojib Bin Zaman, Muhammed Awlad Hussain, Rachel Nye, Varshil Mehta, Kazi Taib Mamun, Naznin Hossain

Abstract readReview
In one paragraph

Review in Cureus, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 307 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
307citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

307 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Characterization of a Novel Quorum QuencherPlants (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Detection ofVeterinary sciences · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Unlocking the potential ofFrontiers in microbiology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Antibacterial Potential of Nanocrystalline Zinc-Cobalt Ferrite.Nanomaterials (Basel, Switzerland) · 2025
    Article

247 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sojib Bin ZamanMaternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh.
Muhammed Awlad HussainProjahnmo Study Site, Johns Hopkin's University Bangladesh.
Rachel NyeHealth Consultant, Botane Skin Activates, Cape Town, South Africa.
Varshil MehtaDepartment of Internal Medicine, MGM Medical College, Navi Mumbai, India.
Kazi Taib MamunNutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh.
Naznin HossainDepartment of Pharmacology, Dhaka Medical College, Dhaka, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics are the 'wonder drugs' to combat microbes. For decades, multiple varieties of antibiotics have not only been used for therapeutic purposes but practiced prophylactically across other industries such as agriculture and animal husbandry. Uncertainty has arisen, as microbes have become resistant to common antibiotics while the host remains unaware that antibiotic resistance has emerged. The aim of this review is to explore the origin, development, and the current state of antibiotic resistance, regulation, and challenges by examining available literature. We found that antibiotic resistance is increasing at an alarming rate. A growing list of infections i.e., pneumonia, tuberculosis, and gonorrhea are becoming harder and at times impossible to treat while antibiotics are becoming less effective. Antibiotic-resistant infections correlate with the level of antibiotic consumption. Non-judicial use of antibiotics is mostly responsible for making the microbes resistant. The antibiotic treatment repertoire for existing or emerging hard-to-treat multidrug-resistant bacterial infections is limited, resulting in high morbidity and mortality report. This review article reiterates the optimal use of antimicrobial medicines in human and animal health to reduce antibiotic resistance. Evidence from the literature suggests that the knowledge regarding antibiotic resistance in the population is still scarce. Therefore, the need of educating patients and the public is essential to fight against the antimicrobial resistance battle.

Indexed as

antibiotic resistanceknowledgerational use

Identifiers

PMID28852600
PMCPMC5573035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.